Separator

Hamilton Lane to set footprint in Asia, Opening an Office in Shanghai

Separator

The announcement by Hamilton Lane of the inauguration of its Shanghai, China office highlights the company's dedication to the Asia Pacific area. The business now has six locations in the area, in addition to those in Hong Kong, Seoul, Singapore, Sydney, and Tokyo.

The Shanghai team, which comprises of seven professionals from the Investment, Client Solutions, Compliance, and Risk Management teams, will be led by Mingchen Xia, Managing Director at Hamilton Lane and Co-Head of Asia Investments.

Juan Delgado-Moreira, Vice Chairman and Head of Asia at Hamilton Lane, said, "I am pleased to see the successful opening of our Shanghai office and would like to thank the team and colleagues who brought this to fruition. China is the world's second-largest economy and is home to the largest private market in Asia. We continue to feel confident in the market and investment opportunities across Asia Pacific, and believe the opening of our Shanghai office will accelerate the growth of our China business and strengthen our leading position in the region."

In May 2022, Shanghai granted Hamilton Lane the designation of Qualified Foreign Limited Partner (QFLP) pilot. Through the QFLP structure, international investors can exchange USD for RMB and invest in RMB private markets. With this approval, Hamilton Lane establishes a secondary fund using a QFLP structure for the first time in Shanghai and starts aggressively looking for investment possibilities in the RMB market.

Xia commented: "We have observed growing demand from domestic institutional and private wealth investors to allocate their capital to global assets, and are thrilled to have an established presence on the ground in Shanghai from which to manage private markets investment programs for investors of all sizes. At Hamilton Lane, we have been investing in the region for more than 15 years and with our new capabilities in the RMB market, we'll be even better positioned to deliver new and differentiated private markets solutions to our clients."

Current Issue